PHMR – Business News Updates

Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval

Dollar jumps, U.S. stocks buck global rally

Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug

Wall Street falls fourth straight day as recession worries nag

Roche’s Alzheimer’s drug fails to meet goal in long awaited trial

U.S. aims to hobble China’s chip industry with sweeping new export rules

Exclusive: Apollo, Sixth Street no longer in talks to finance Twitter deal

Eisai, Biogen say Alzheimer’s drug succeeds in slowing cognitive decline

Novartis to prioritise U.S. market unfazed by drug pricing pushback

Wall Street set for higher open as focus shifts to inflation data